Li, J., M. Hu, H. Xu, X. Yu, F. Ye, K. Wang and D. Zhang, 2016. Influence of type and proportion of lyoprotectants on lyophilized ginsenoside Rg3 liposomes. J. Pharm. Pharmacol., 68: 1-13. CrossRef | Direct Link |
Yu, X., H. Xu, M. Hu, X. Luan, K. Wang, Y. Fu and J. Li, 2015. Ginsenoside Rg3 bile salt-phosphatidylcholine-based mixed micelles: Design, characterization, and evaluation. Chem. Pharm. Bull., 63: 361-368. CrossRef | Direct Link |
Xu, H., M. Hu, X. Yu, Y. Li, Y. Fu, X. Zhou and J. Li, 2015. Design and evaluation of pH-sensitive liposomes constructed by poly (2-ethyl-2-oxazoline)-cholesterol hemisuccinate for doxorubicin delivery. Eur. J. Pharm. Biopharm., 91: 66-74. CrossRef | Direct Link |
Xu, H., F. Ye, M. Hu, P. Yin, W. Zhang, Y. Li and Y. Deng, 2015. Influence of phospholipid types and animal models on the accelerated blood clearance phenomenon of PEGylated liposomes upon repeated injection. Drug delivery, 22: 598-607. CrossRef | Direct Link |
Xu, H., W. Zhang, Y. Li, F.Y. Fei, P. P. Yin, X. Yu, and D.J. Shang, 2014. The bifunctional liposomes constructed by poly(2-ethyl-oxazoline)-cholesteryl methyl carbonate: an effectual approach to enhance liposomal circulation time, ph-sensitivity and endosomal escape. Pharm. Res., 31: 3038-3050. Direct Link |
Xu, H., Y.H. Deng, K.Q. Wang and D.W. Chen, 2012. Preparation and characterization of stable pH-sensitive vesicles composed of α-tocopherol hemisuccinate. AAPS Pharm. Sci. Tech,, 13: 1377-1385. Direct Link |
Xu, H., K.Q. Wang, Y.H. Deng and D.W. Chen, 2010. Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of pegylated liposomes. Biomaterials, 31: 4757-4763. CrossRef |
Xu, H., Y. Deng, D. Chen, W. Hong, Y. Lu and X. Dong, 2008. Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives. J. Controlled Release, 130: 238-245. CrossRef |
Xu, H., Y. Deng, D. Chen, J. Qin, J. Liu, L. Shi and Y. Lu, 2008. Preparation and characterization of pH-sensitive vesicles made of cholesteryl hemisuccinate. Drug dev. Ind. Pharm., 34: 134-141. CrossRef | Direct Link |